Point72 Asset Management
MEDS

Point72 Asset Management’s DataMeds AI, Inc. Common Stock MEDS Stock Holding History

Point72 Asset Management’s Portfolio MEDS Stock Details MEDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.63K Buy
546
+254
+87% +$3.49K ﹤0.01% 3704
2025
Q4 		$5.84K Buy
+292
New +$8.56K ﹤0.01% 3850

Other funds holding MEDS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VFIC
Valley Forge Investment Consultants Audubon, Pennsylvania $334M AUM 17.84% 1-Year Est. Return

Point72 Asset Management's MEDS Position: Q1 2026 in Review

Point72 Asset Management increased its DataMeds AI, Inc. Common Stock (MEDS) stake by 87% in Q1 2026, buying an estimated $3.49K and bringing the position to 546 shares worth $2.63K. The position accounts for ﹤0.01% of the portfolio, ranked #3704.

Point72 Asset Management first reported a position in MEDS in Q4 2025 and has held it in 2 quarters since. The position peaked at $5.84K in Q4 2025. 13 funds tracked by Wall St. Rank hold MEDS as of Q1 2026.

  • Point72 Asset Management held 546 shares of DataMeds AI, Inc. Common Stock worth $2.63K as of Q1 2026.
  • Point72 Asset Management bought 254 DataMeds AI, Inc. Common Stock shares in Q1 2026, an estimated $3.49K.
  • DataMeds AI, Inc. Common Stock made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #3704 holding.
  • Point72 Asset Management first reported a position in DataMeds AI, Inc. Common Stock in Q4 2025 and has held it in 2 quarters since.
  • Point72 Asset Management's DataMeds AI, Inc. Common Stock position peaked at $5.84K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held DataMeds AI, Inc. Common Stock as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.